372 related articles for article (PubMed ID: 7685923)
1. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
5. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
Xu W; Shen Y; Chen RZ; Xiong SD
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
[TBL] [Abstract][Full Text] [Related]
6. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
7. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci.
Huber SA; Moraska A; Cunningham M
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5543-7. PubMed ID: 8202524
[TBL] [Abstract][Full Text] [Related]
8. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes.
Huber SA
Lab Invest; 1992 Aug; 67(2):218-24. PubMed ID: 1323730
[TBL] [Abstract][Full Text] [Related]
9. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Yue Y; Xu W; Hu L; Jiang Z; Xiong S
Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
[TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus B-3-induced myocarditis. Virus and actinomycin D treatment of myocytes induces novel antigens recognized by cytolytic T lymphocytes.
Huber SA; Heintz N; Tracy R
J Immunol; 1988 Nov; 141(9):3214-9. PubMed ID: 2459248
[TBL] [Abstract][Full Text] [Related]
11. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
12. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
Huber SA; Lyden DC; Lodge PA
Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
[TBL] [Abstract][Full Text] [Related]
15. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
Zhang H; Yousef GE; Ouyang X; Archard LC
Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
[TBL] [Abstract][Full Text] [Related]
17. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
18. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
Huber SA; Moraska A; Choate M
J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of T cell receptor Vbeta gene usage of cytolytic T-lymphocytes in coxsackievirus B3-induced myocarditis].
Wang YB; Hua YM; Shi XQ; Yang Y; Wei DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):80-3. PubMed ID: 16468649
[TBL] [Abstract][Full Text] [Related]
20. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
Guthrie M; Lodge PA; Huber SA
Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
